Gallopamil slow release: a double blind
β
H. S. Markus; E. M. F. Chong; R. G. Wilcox
π
Article
π
1992
π
Springer
π
English
β 290 KB
The clinical efficacy of a new slow release preparation of the calcium antagonist gallopamil was assessed in 20 patients by diary cards and treadmill exercise tests. A single blind phase of two week periods of placebo, gallopamil 100 mg o.d. and gallopamil 100 mg b.i.d., blinded to the patient, was